Press Releases
 
Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific

Asia-Pacific CRO Novotech has acquired Australasian specialist CRO Clinical Network Services (CNS), with a mutual mission to expand services

SYDNEY, 19 October 2018 -- (ACN Newswire) -- Novotech, the largest Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services (CNS), as part of a mutual mission to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials. Both companies will continue to retain their separate brands and identities.

Early phase CNS clients, wishing to advance into later phase regional trials, can tap into Novotech's Asia-Pacific expertise backed by 10 partnership agreements with leading hospitals and medical institutions, offering access to 1.4 billion people living in urban areas across the region. Novotech has 400+ staff across Asia-Pacific and business development offices in the USA. CNS has more than 140 staff in Australia, New Zealand and the USA.

As part of the deal, clients can access leading services from both groups, including the CNS BioDesk, which provides early stage product development advice including toxicology, CMC and FDA/EMA regulatory consulting and interactions; and Novotech's advanced regional IT infrastructure, to support their clinical research programs.

Novotech CEO John Moller said:

"Biopharma clients should know this acquisition is a bringing together of the highest quality CROs in the region. Very importantly, we have developed remarkably similar company cultures, and I know the teams are excited about the opportunity of working together.

"Novotech and CNS will continue to operate under separate brands with CNS specialising in early phase non-oncology clinical trials across Australia and New Zealand, and Novotech specialising in regional Asia-Pacific and global project delivery across all phases.

"Our Asia-Pacific in-country relationships enable a comprehensive understanding of local regulatory requirements and changes, access to leading investigators, strong site connections, and accessible patient populations to deliver success for our clients within timelines and budgets."

CNS Managing Director Russ Neal commented:

"Early phase research in Australasia has seen incredible growth over the last 6-7 years and CNS is proud to be a significant part of this proven capability. As our clients have experienced success with us, we have often wished we had the international reach to continue supporting them.

"This truly complimentary association with Novotech now means that we are able to offer our clients access to Novotech's Asia-Pacific experience and expertise in later phase regional or global trials. On the other hand, Novotech clients can access our highly regarded global product development and regulatory affairs consultancy team, BioDesk, based out of Washington DC, London and Australia"

CNS COO and Executive Director Gabrielle McKee further added:

"CNS clients will also benefit from many of Novotech's strengths, including IT infrastructure and specialist functions such as legal, learning and development, marketing and analytics,. and particularly exciting, CNS and Novotech offer our clients one of the most experienced and knowledgeable biometrics teams in the region, with 70 staff in the combined unit."

About Novotech - https://novotech-cro.com/welcome
Headquartered in Sydney, Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia-Pacific region.

Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech's strong Asia-Pacific presence includes running clinical trials in all key regional markets, with a worldwide reach through the company's network of strategic partners.

About Clinical Network Services (CNS) - https://clinical.net.au/
Clinical Network Services (CNS) is an integrated service group focused on product development. Headquartered in Australia, with offices in New Zealand, the UK and the USA, CNS creates value for small to medium sized biotechnology companies by progressing early stage products through phase 1 & 2 clinical trials or the marketplace sooner.

CNS offers a unique service, integrating BioDesk, an intelligent global product development and regulatory affairs consultancy, with its committed, highly experienced Australian/New Zealand clinical services and biometrics team. CNS' regional clinical advantage is driven by the extremely pragmatic regulatory environment in Australia and New Zealand that makes it possible for clients to enter the clinic quickly, without prior regulatory approval.

CNS offers a uniquely differentiated, customer-orientated, suite of services to clients which enables it to guide products efficiently through critical post-discovery development and into initial human trials. Throughout, CNS takes a global development/ regulatory strategic approach to ensure that value is added at every stage of the product development life cycle.

Media Contact:
Susan Fitzpatrick-Napier

USA: +1 415 951 3228
AUS: +61 2 8218 2144
ASIA: +65 3159 3427

# # #


Submitted by ACN Newswire, ACN Newswire on Friday, 19 October 2018 at 9:25 AM
Category: Health Care & Medical
 
Related News

Biomedical Waste Management Market Share and Growth Factors Impact Analysis 2017 - 2025
Tuesday, 20 Nov 2018

Neonatal Conjunctivitis Treatment Market: Current Trends and Future Aspect Analysis 2025
Tuesday, 20 Nov 2018

Retinoblastoma Treatment Market Research and Analyzed Report for 2018 - 2026
Tuesday, 20 Nov 2018

Lung Cancer Therapeutics Market Report 2017 and Future Opportunity Assessment 2025
Tuesday, 20 Nov 2018

Infantile Spasms Therapeutics Market Growth, Capacity, Scope, Revenue, Key-Players, and Forecast unt
Tuesday, 20 Nov 2018

Related Events

CPMED 2018: 2nd Summit on Controversies in Precision Medicine
Monday, 19 Nov 2018

Dexeus Forum 2018-Obstetrics, Gynaecology and Reproductive Medicine
Wednesday, 21 Nov 2018

7th IFAD (International Fluid Academy Days)
Friday, 23 Nov 2018

AbbVie Hackathon
Friday, 23 Nov 2018

OmniaMed Kongress-Highlights Kardiologie Munchen 2018
Friday, 23 Nov 2018

Latest News

Changfeng Energy Announces the Meishan Integrated District Energy Distribution Project
Tuesday, 20 Nov 2018

Life Insurance - Best One Life Insurance Guru
Tuesday, 20 Nov 2018

Power Banks and Factors to possess One
Tuesday, 20 Nov 2018

Orphan Drugs Market is Anticipated to Reach a Value of US$318.5 bn by 2025
Tuesday, 20 Nov 2018

Drug and Gene Delivery Systems Market to Expand at a Modest CAGR of 6% by 2025
Tuesday, 20 Nov 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 20 November 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 13th EPP European and Global Pricing Forum, 2018 Brussels
  • SBM Will Attend the Bauma CHINA 2018 Shanghai
  • QS World MBA/Grad School Tour Manila - 19-20th November - Free Entry!
  • CPMED 2018: 2nd Summit on Controversies in Precision Medicine
  • 5th Annual CEM and Customer Loyalty MENA Summit

  • Latest Jobs
    Sorry, there are currently no entries posted here.